DT Eurich, SR Majumdar, RT Tsuyuki, JA Johnson - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND SETTINGS—Using the Saskatchewan health databases, 12,272 new users of oral
hypoglycemic agents were identified between the years of 1991 and 1996. We excluded 3,202 subjects
with previous cardiovascular ... Cited by 32 - Related articles - BL Direct - All 6 versions
TH Hostetter - Journal of the American Society of Nephrology, 2002 - Am Soc Nephrol Over the last 25 years, the approach to the patient with chronic kidney disease (CKD) has distinctly
changed, and that transformation has only accelerated in the recent decade. We have gone from
providing only relatively minor ... Cited by 18 - Related articles - BL Direct - All 4 versions
E Ritz - New England Journal of Medicine, 2003 - content.nejm.org Diabetes mellitus causes a dramatic increase in mortality, particularly from cardiovascular causes:
the survival rate among persons with either type 1 or type 2 diabetes and no history of coronary
heart disease was reported to be as ... Cited by 47 - Related articles - BL Direct - All 5 versions
JA Johnson, SH Simpson, EL Toth, SR … - Diabetic …, 2005 - interscience.wiley.com Methods We conducted a retrospective cohort analysis, using Saskatchewan Health administrative
databases to identify new users of oral antidiabetic drugs. Subject groups were defined by
medication use during 1991–1999: ... Cited by 40 - Related articles - All 6 versions
CJ Turner, P Parfrey, K Ryan, R Miller, A Brown - American Journal of Health- …, 2000 - ASHP C HRISTOPHER J. T URNER , P H .D., is Director of Experiential Programs, School of Pharmacy,
University of Colorado Health Sciences Center, Denver; when this study was conducted he was
Associate Professor of Clinical ... Cited by 9 - Related articles - BL Direct - All 6 versions
AL Kamper, S Strandgaard, PP Leyssac - Nephrology Dialysis …, 1995 - ERA-EDTA Abstract. An earlier controlled trial showed that over an average of 26 months, enalapril slowed the
progres- sion of chronic renal failure. Following completion of the trial, the patients continued to
receive antihyper- tensive ... Cited by 10 - Related articles - BL Direct - All 3 versions
[CITATION] Macrovascular disease: the sword of Damocles in diabetes
T Wu, B Brooks, D Yue - Diabetes in the New Millennium. Sydney, Australia: …, 1999 Cited by 12 - Related articles
- ►diabetesjournals.org JA Johnson, SR Majumdar, SH Simpson, EL Toth - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Saskatchewan Health databases were used to examine population-based
mortality rates for new users of oral antidiabetic agents. Individuals with prescriptions for
sulfonylurea or metformin in ... Cited by 154 - Related articles - BL Direct - All 7 versions
RT Tsuyuki, KL Olson, KK Teo - CPJ, Canadian pharmaceutical journal, 1999 - cat.inist.fr NITROGLYCERIN AS AN INDICATOR FOR THE PRESENCE OF CORONARY HEART DISEAS. RT TSUYUKI, KL OLSON, KK TEO
CPJ, Canadian pharmaceutical journal 132:88, 32-36, Canadian Pharmacists Association, 1999.
Cited by 13 - Related articles - BL Direct
- ►canadianmedicaljournal.ca LC Brown, JA Johnson, SR Majumdar, RT … - Canadian Medical …, 2004 - Can Med Assoc Methods: Administrative records from Saskatchewan Health were used to evaluate the use of
antiplatelet agents, statins and angiotensin-converting enzyme (ACE) inhibitors by people with
treated type 2 diabetes with and ... Cited by 73 - Related articles - BL Direct - All 14 versions
